Company: NIVFW
Filing Date: 2025-06-03
Form Type: 424B3
Source: 0001213900-25-050825
Chunk: 0

Company: NewGenIvf Group Ltd
Filing Date: 2025-06-03
Form: 424B3
Chunk 0
---
Filed Pursuant to Rule 424(b)(3)

Registration No. 333-285629

<div align='center'>PROSPECTUS

22,027,500 Class A Ordinary Shares

NewGenIvf Group Limited</div>

This prospectus relates to
the resale by the selling securityholders identified in this prospectus (“Selling Securityholders”) of up to 22,027,500 Class
A Ordinary Shares, no par value per share (“Class A Ordinary Shares”), consisting of (i) 12,500 Class A Ordinary Shares issued
to Genetics & IVF Institute, Inc. (“GIVF”) in connection with the Purchase Agreement dated as of January 21, 2025, by
and between the Company and GIVF (“MicroSort Purchase Agreement”); and (ii) 15,000 Class A Ordinary Shares issued to A SPAC
Holdings Group Corp. (“ASPAC”) in connection with a consulting services agreement dated as of February 24, 2025, by and between
the Company and ASPAC (“ASPAC Agreement”); (iii) an additional 12,000,000 Class A Ordinary Shares issuable to JAK Opportunities
VI LLC upon the conversion of (a) the Remaining Additional Notes (as defined below), (b) the senior convertible notes exchanged on August
8, 2024 (“Exchange Notes”), (c) the exercise of Series A warrants to purchase Class A Ordinary Shares (the “Series
A Warrants”), (d) the exercise of Series B warrants to purchase Class A Ordinary Shares (the “Series B Warrants”),
(e) the exercise of Series C warrants to purchase Class A Ordinary Shares (the “Exchange Warrants” and together with the
Series A Warrants and the Series B Warrants, the “Warrants”), and (f) the New CB Initial Note (as defined below); and (iv)
10,000,000 Class A Ordinary Shares issuable by the Company to White Lion Capital, LLC (“White Lion”) in connection with the
Common Stock Purchase Agreement dated as of November 21, 2024, by and between the Company and White Lion (the “White Lion Purchase
Agreement”) (the “Resale Shares”). The Resale Shares were issued in private placements to certain Selling Securityholders.

We are registering the offer
and resale of the Resale Shares to satisfy certain registration rights we have granted. The Resale Shares will be resold from time to
time by the Selling